Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
positive regulation of blood circulation	GO_1903524	[Any process that activates or increases the frequency, rate or extent of blood circulation.]
negative regulation of isoprenoid metabolic process	GO_0045827	[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.]
positive regulation of isoprenoid metabolic process	GO_0045828	[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.]
negative regulation of glycolytic process	GO_0045820	[Any process that stops, prevents, or reduces the frequency, rate or extent of glycolysis.]
regulation of glycolytic process	GO_0006110	[Any process that modulates the frequency, rate or extent of glycolysis.]
negative regulation of ATP metabolic process	GO_1903579	[Any process that stops, prevents or reduces the frequency, rate or extent of ATP metabolic process.]
negative regulation of phosphorylation	GO_0042326	[Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.]
negative regulation of purine nucleotide metabolic process	GO_1900543	[Any process that stops, prevents or reduces the frequency, rate or extent of purine nucleotide metabolic process.]
glycolytic process	GO_0006096	[The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.]
positive regulation of glycolytic process	GO_0045821	[Any process that activates or increases the frequency, rate or extent of glycolysis.]
positive regulation of phosphorylation	GO_0042327	[Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.]
positive regulation of purine nucleotide metabolic process	GO_1900544	[Any process that activates or increases the frequency, rate or extent of purine nucleotide metabolic process.]
positive regulation of ATP metabolic process	GO_1903580	[Any process that activates or increases the frequency, rate or extent of ATP metabolic process.]
positive regulation of striated muscle tissue development	GO_0045844	[Any process that activates or increases the frequency, rate or extent of striated muscle development.]
Morgagni diaphragmatic hernia	HP_0025194	[An anterior retrosternal or parasternal hernia that can result in the herniation of liver or intestines into the chest cavity.]
Central diaphragmatic hernia	HP_0025195	[A congenital diaphragm defect involving the central tendinous (e.g., amuscular) portion of the diaphragm, whereby the entire rim of diaphragmatic musculature is present.]
Subtentorial periventricular white matter hyperdensity	HP_0025192	[Areas of brighter than expected signal on magnetic resonance imaging emanating from the cerebral white matter that surrounds the fourth cerebral ventricle (which is located beneath the tentorium of the cerebellum).]
Posterolateral diaphragmatic hernia	HP_0025193	[A posterolateral defect in the diaphragm, commonly referred to as a Bochdalek hernia, which is often accompanied by herniation of the stomach, intestines, liver, and/or spleen into the chest cavity.]
Inflammatory cap polyp	HP_0025198	[A non-malignant sessile or pedunculated polyp in the colon and rectum that displays a cap of inflammatory granulation tissue with fibrinopurulent exudate that covers the polyp.]
Increased total iron binding capacity	HP_0025196	[An elevation in the total-iron binding capacity, which measures how much serum iron is bound if an excess of radioactive iron is added. A high TIBC corresponds to a high transferrin concentration. The latent (or free) iron binding capacity is the difference between the TIBC and the measured serum iron, corresponding to the transferrin not bound to iron, i.e., free iron binding capacity.]